Drugs targeting DNA methylation and histone modifications, such as DNA methyltransferase inhibitors (DNMTis) and HDAC inhibitors, are actively explored for cancer therapy, demonstrating promising results in hematologic and solid tumors (28). Here, HDAC9 is linked to cancer.